1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Cell Therapy
  6.  » How to Commercially Scale T-cell Allogeneic Therapies

How to Commercially Scale T-cell Allogeneic Therapies

Summary: In this presentation, Jesse Trekker, PhD, Business Development Director at Catalent Cell & Gene Therapy, discusses an innovative manufacturing methodology and fill/finish approaches to accelerate T-cell therapies to the commercial readiness phase.

 

Click here to download the Webinar